Posted Jun. 27, 2013 at 12:48 p.m.

Premium Lock GSK's muscular dystrophy drug granted breakthrough status

Published: 2013-06-27 12:48:46
Updated: 2013-06-27 12:48:46

Print this blog post
GSK GSK

GlaxoSmithKline's experimental treatment for Duchenne Muscular Dystrophy is now classified by the FDA as a "breakthrough therapy."...

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll